Tag

Secondary Prevention

All articles tagged with #secondary prevention

Underutilization of Aspirin Despite its Heart Attack and Stroke Risk Reduction Potential
health2 years ago

Underutilization of Aspirin Despite its Heart Attack and Stroke Risk Reduction Potential

A new study reveals that less than half of the individuals who could benefit from taking aspirin for secondary prevention of cardiovascular disease actually use it. The analysis of health surveys from 51 countries shows that aspirin use following a heart attack or stroke ranged from about 17 percent in low-income countries to about 65 percent in high-income countries. With cardiovascular disease being the leading cause of mortality worldwide, the low aspirin usage among this population is concerning. While the risks and benefits of aspirin use for primary prevention have been debated, aspirin has shown to be effective in preventing a second cardiovascular event. However, some patients may stop taking aspirin due to concerns about side effects or financial constraints. Experts emphasize the importance of consulting with a doctor before starting or discontinuing aspirin therapy.

The Importance of Aspirin Adherence in Preventing Heart Attacks and Recurrence
health2 years ago

The Importance of Aspirin Adherence in Preventing Heart Attacks and Recurrence

Less than half of adults with a history of cardiovascular disease are taking aspirin to prevent another heart attack or stroke, according to a new study. The research found that only about 40% of eligible patients worldwide are using aspirin for secondary prevention, with rates varying by country. Low-income countries had the lowest usage rates, while high-income countries had the highest. Aspirin is a cost-effective tool for reducing the risk of cardiovascular events, but its underutilization highlights the need for improved access and awareness of its benefits.

Reconsidering Long-Term Beta-Blocker Use After Heart Attack
cardiology2 years ago

Reconsidering Long-Term Beta-Blocker Use After Heart Attack

Beta-blocker treatment beyond 1 year after myocardial infarction (MI) for patients without heart failure or left ventricular systolic dysfunction was not associated with improved cardiovascular outcomes in a new analysis of a nationwide cohort of more than 40,000 patients. The study was published online in Heart on May 2. The authors suggest that determining whether beta-blockers are indicated beyond the first year after MI may have an impact on patient health-related quality of life. More evidence from large randomized clinical trials is needed to answer this question.